0.7701USD-2.52%Mkt Cap: 32.36M $P/E: —2d ago
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap32.36M $
Enterprise Value21.73M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.44M $
Revenue/Share—
Last Price0.7701 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.73
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.20
EPS (TTM)-1.16
EPS (Forward)-0.41
52W Range
0.60009% of range2.450
52W High2.450 USD
52W Low0.6000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.49%
ROA-94.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M $
CapEx (TTM)—
FCF Margin—
FCF Yield-3.11%
Net Debt-8.11M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio200.08
Quick Ratio198.75
Book Value/Sh0.2220 USD
Cash/Share0.1930 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.02M
Float35.03M
Insiders30.58%
Institutions5.42%
Short Interest
Short Ratio3.5d
Short % Float0.53%
Short % Out.0.49%
Shares Short205.41K
Short (prev mo.)189.32K
Technical
SMA 500.8696 (-11.4%)
SMA 2001.149 (-32.9%)
Beta1.55
S&P 52W Chg18.16%
Avg Vol (30d)84.68K
Avg Vol (10d)65.12K
Technical Indicators
RSI (14)44.8
MACD-0.0381
MACD Signal-0.0484
MACD Hist.+0.0103
BB Upper0.9552 USD
BB Middle0.7824 USD
BB Lower0.6097 USD
BB Width44.16%
ATR (14)0.0636 USD
Vol Ratio (20d)0.41x